CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading organization profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Organizations/nonprofit

nonprofit organization

BioCruces Health research Institute

ES

OPENALEX: I4210089430↗ROR: 0061s4v88↗

People

Connected researchers

Igor HorrilloORCID 0000-0003-0125-5884 J Javier MeanaORCID 0000-0002-7913-6714 Leyre UrigüenORCID 0000-0002-1296-6895 Luis F CalladoORCID 0000-0001-9941-012X Paula Unzueta-LarrinagaORCID 0000-0001-8325-2235 Rebeca Diez-AlarciaORCID 0000-0002-0806-9825 S MatoORCID 0000-0002-2005-9793

Public evidence

2 connected articles

Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients.2022 · Europe PMC Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway.2018 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: OpenAlex.

BioCruces Health research Institute - Medical Cannabis Research Engine